phe885
gracell,bms,novartis
['phe885', '$bmy', '$grcl', '$nvs']
$nvs claims 100% manufacturing success with phe885 (t-charge anti-bcma car-t). 100% orr at "active" doses. 2 notable deaths, one deemed related. via adam sperling #asco23 $bmy $grcl 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.